Kathy Giusti, M.B.A. ’85, founder and CEO of the Multiple Myeloma Research Foundation (MMRF), will address this year's imminent graduates of Harvard Business School as Class Day speaker. She founded the MMRF in 1998 after being diagnosed with multiple myeloma. This spring, Time magazine named her one of the "100 most influential people" in the world. Multiple myeloma is a cancer of plasma cells—white blood cells that produce antibodies; it affects from one to four people per 100,000 and constitutes 1 percent of all cancers. Before starting MMRF, Giusti was an executive with pharmaceutical companies, and she has sought to encourage the development of drugs to treat the disease using a business model, rather than an academic model, of drug development. The MMRF is the world's top funder of myeloma research: it has raised more than $165 million to fund research.
Multiple myeloma research crusader Kathy Giusti to speak at HBS Class Day
The founder of the Multiple Myeloma Research Foundation will speak at Harvard Business School Class Day.
Kathy Giusti | Photograph courtesy of the Multiple Myeloma Research Foundation
You might also like
Cancellations, Disruptions as Harvard Graduate Student Strike Enters Second Week
Some faculty complain about the protests’ effect on students.
FAS Reports Financial Stability, But Rising Debt
Leaders say the cost of consultants and severance will be recouped within 18 months.
As Union Protests Continue, Stephen Colbert and Yo-Yo Ma Event at Harvard Cut Short
A conversation between the comedian and the celebrated cellist was interrupted by a fire alarm in Sanders Theatre.
Most popular
Explore More From Current Issue
As humanities shrink across higher education, one department is flourishing. Is its success a fluke, or a roadmap?
Artists Enzo Camacho and Ami Lien turn a colonial symbol from Cambodia inside out.
Why Harvard Medical School is training physicians to think more like coaches